Clinical trials
Parkinsonism clinical trials
Below are recruiting parkinsonism clinical trials, each written for real people, not researchers. We’re tracking 735 recruiting studies, each written for real people, not researchers, below.
Recruiting studies
- NCT07170475RecruitingPhase 1
Study of febuxostat and inosine for Parkinson's disease
This trial tests whether a combination of two supplements, febuxostat and inosine, can help people with Parkinson's disease. It aims to see if this treatment is safe and may improve symptoms.
Toyoake, Aichi-kenAges 18–80 - NCT05778617RecruitingPhase 3
Ambroxol to Slow Parkinson’s Disease Progression
This trial studies whether ambroxol (or a placebo) can slow the progression of Parkinson’s disease. It may help by aiming to change how the disease develops over time.
BirminghamAges 35–75 - NCT06438419Recruiting
Brain activity in Parkinson's during movement with DBS
This study records brain activity during movement in people with Parkinson's who have a special deep brain stimulation (DBS) device. It aims to understand how brain rhythms relate to movement, which could improve future treatments.
BordeauxAges 18–75 - NCT07157345RecruitingPhase 1
Testing PDR-001 for Parkinson's Disease
This trial tests a new drug, PDR-001, to see if it can safely remove harmful proteins from the brain in people with early Parkinson's disease. It may help slow down the disease.
Shanghai, Shanghai MunicipalityAges 40–65 - NCT07163156Enrolling by invitation
Prolactin and inflammation in Parkinson's severity
This study looks at whether prolactin (a hormone) and inflammation markers in blood and saliva are related to the severity of Parkinson's disease. It may help identify new ways to track the disease.
Çanakkale, MerkezAges 18 years+ - NCT07157735RecruitingPhase 2
Testing an anti-inflammatory drug for early Parkinson's disease
This trial tests whether the anti-inflammatory drug dapansutrile can help people with early Parkinson's disease. You would get either dapansutrile or a placebo (a pill with no active drug) to see if it slows the disease.
CambridgeAges 50–80 - NCT07156773RecruitingPhase 2
Nasal spray for Parkinson's off episodes
This study tests a new nasal spray called XJN010 for people with Parkinson's who have 'off' episodes—times when their regular medication wears off and symptoms come back. The goal is to see if the spray can safely and effectively help during those periods.
Guangzhou, GuangdongAges 30–85 - NCT06955377Recruiting
Bending forward and airway protection in Parkinson's disease
This study looks at how bending forward (trunk flexion) affects your body's ability to protect your airway in Parkinson's disease. It may help understand breathing risks and guide therapy.
PragueAges 18 years+ - NCT07153692Recruiting
Brain stimulation for swallowing problems in Parkinson's
This study is testing whether a gentle brain-stimulation technique called tDCS can help people with Parkinson's disease who have trouble swallowing. If you have Parkinson's, multiple system atrophy, or progressive supranuclear palsy and a swallowing problem, this trial may be an option.
Hangzhou, ZhejiangAges 18–100 - NCT07151378RecruitingPhase 3
Intestinal gel for Parkinson's mood and behavior problems
This trial tests a gel form of levodopa (called Lecigon) given through a tube into the intestine to see if it helps reduce mood swings, impulsive behaviors, and other mental side effects in people with Parkinson's who already have motor fluctuations. It is for people who have had Parkinson's for at least 5 years and are between 18 and 75 years old.
Saarlouis, SaarlandAges 18–75 - NCT06732180RecruitingPhase 1
Testing a new drug (GT-02287) for Parkinson's disease
This trial tests an investigational drug called GT-02287 in people with early-stage Parkinson's disease (diagnosed within the last 7 years). The goal is to see if it is safe and how the body processes it, with a special focus on people with certain genetic changes (GBA1 mutations) that may be linked to Parkinson's.
Darlinghurst, New South WalesAges 30–85 - NCT07142044RecruitingPhase 1/Phase 2
Testing EC5026 for Parkinson's disease
This study tests a new oral medication called EC5026 for Parkinson's disease. It aims to see if the drug is safe and if it might help control symptoms when added to your current levodopa treatment.
Sacramento, CaliforniaAges 50–80 - NCT07134634Recruiting
Vibrating therapy ball for tremor relief
This trial tests whether a vibrating ball can help reduce tremor and make daily tasks easier. It is for people with different types of tremor, as long as they don't have major thinking problems or certain other health issues.
Beelitz, BrandenburgAges Any age - NCT05171205Recruiting
Spinal cord stimulation for people with parkinsonism symptoms
This trial studies whether spinal cord stimulation can improve symptoms in people with parkinsonism (Parkinson-like movement problems). It aims to see if the treatment is safe and helpful for the right patients.
Shanghai, Shanghai MunicipalityAges 50–80 - NCT07118956Recruiting
Ear stimulation for apathy in Parkinson's
This trial tests whether a gentle electrical stimulation on your ear (taVNS) can help improve low motivation (apathy) in people with Parkinson's. It also uses MRI scans to see how the treatment affects the brain.
Hefei, AnhuiAges 40–90 - NCT07110376Recruiting
Brain recordings during sleep with deep brain stimulation for Parkinson's
This study looks at brain activity during sleep in people with Parkinson's who have a deep brain stimulation (DBS) device. It aims to understand how different DBS settings affect sleep, which may help improve treatment.
Cleveland, OhioAges 18 years+ - NCT07115563Recruiting
Amino acid supplement test for Parkinson's disease
This trial tests if taking daily amino acid supplements helps people with Parkinson's disease. You need to be on stable Parkinson's medication for at least 3 months.
Farmington, ConnecticutAges 50–90 - NCT06967493Recruiting
Amazonian dance for Parkinson's motor and non-motor symptoms
This trial studies whether learning Amazonian dance can improve movement and mood in people with Parkinson's. If you are in early to moderate stages and can walk on your own, you may be able to join.
Castanhal, PennsylvaniaAges 50–80 - NCT07105787Recruiting
Parkinson's exercise study: Tel Aviv and Bologna
This trial tests whether a specific exercise program can improve walking and movement in people with early to moderate Parkinson's disease. If you have trouble with your gait or balance, this study may offer a supervised exercise program to help manage symptoms.
Tel AvivAges Any age - NCT07097298Recruiting
Empathy and compassion study for Parkinson's patients and caregivers
This study explores empathy and self-compassion in people with Parkinson's disease and their caregivers. If you have mild to moderate Parkinson's and a caregiver at home, you and your caregiver may join together to help researchers understand how to better support both of you.
LuganoAges 50–80 - NCT07096336Recruiting
Vitamin D3 and brain waves in Parkinson's study
This study tests whether taking vitamin D3 can improve brain wave patterns in men with Parkinson's disease who have low vitamin D levels. It may help understand if vitamin D supports brain health.
Dhaka, ShahbagAges 51–70 - NCT07102342RecruitingPhase 1/Phase 2
Cell therapy for Parkinson's disease
This trial tests a new cell treatment for Parkinson's disease. It involves injecting special cells into the brain to see if they can safely replace damaged cells and improve symptoms. It might help people who have had Parkinson's for several years and still respond well to medication.
New York, New YorkAges 30–75 - NCT07100171RecruitingEarly Phase 1
GM101 injection for advanced Parkinson's disease
This trial tests an investigational gene therapy injection called GM101 for people with advanced Parkinson's disease whose symptoms are not well controlled by standard medications. The study will see if this treatment can help improve movement and quality of life.
ChangshaAges 40–70 - NCT07092995Enrolling by invitation
Understanding freezing of gait in Parkinson's using VR and brain signals
This study uses virtual reality and brain recordings from your DBS device to understand why some people with Parkinson's experience freezing of gait (feeling like your feet are stuck to the ground). You'll be asked to walk in a safe VR environment while researchers monitor your brain activity.
Los Angeles, CaliforniaAges 18 years+
Hear when a new Parkinsonism trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.
Common questions
- Are there clinical trials for parkinsonism?
- Yes. Clin2 currently lists 735 recruiting parkinsonism studies from the U.S. registry, each rewritten for real people, not researchers, so you can see what it’s testing and who it’s for.
- How do I know if I qualify for a parkinsonism trial?
- Each study lists its eligibility criteria — rules about age, diagnosis, and prior treatments. On every Clin2 trial page we explain these in words written for real people and offer a short, optional pre-screen for a fit read. The study team makes the final decision.
- Does it cost anything to join a parkinsonism trial?
- Using Clin2 is always free. Many trials cover the cost of the study treatment and related visits; some reimburse travel. The study team explains exactly what’s covered before you decide.
Related conditions
Clin2 helps you find and understand clinical trials and does not provide medical advice. Study data comes from ClinicalTrials.gov. Talk with your doctor about whether a specific trial is right for you.